Aspect Biosystems is a biotechnology company specializing in microfluidic 3D bioprinting and tissue engineering. In addition, it is focused on partnering with pharmaceutical and biotechnology companies to enable the creation of human tissues for medical research, discovery, and regenerative medicine products.
|Employees (est.) (Jun 2020)||43||(+5%)|
Aspect Biosystems total Funding
Aspect Biosystems latest funding size
Time since last funding
|5 months ago|
Aspect Biosystems investors
|Pangaea Ventures, Tom Williams, Pallasite Ventures, Hedgewood, Radical Ventures, Rising Tide, Endure Capital, Genome British Columbia, Western Innovation (WINN) Initiative, Rhino Ventures, Relentless Pursuit Partners|
Aspect Biosystems has 1.5k Twitter Followers. The number of followers has increased 1.5% month over month and increased 5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Aspect Biosystems founded?
Aspect Biosystems was founded in 2013.
Who are Aspect Biosystems key executives?
Aspect Biosystems's key executives are Tamer Mohamed, Sam Wadsworth and Simon Beyer.
How many employees does Aspect Biosystems have?
Aspect Biosystems has 43 employees.
Who are Aspect Biosystems competitors?
Competitors of Aspect Biosystems include TissueLabs, Advanced BioMatrix and Revotek.
Where is Aspect Biosystems headquarters?
Aspect Biosystems headquarters is located at 1781 W 75th Ave, Vancouver.
Where are Aspect Biosystems offices?
Aspect Biosystems has an office in Vancouver.
How many offices does Aspect Biosystems have?
Aspect Biosystems has 1 office.
Receive alerts for 300+ data fields across thousands of companies